New York University

Institut Pasteur

Institute Pasteur

Shirley Longacre-Andre

John W Barnwell

Faridabano Nato

Charles W Roth

Kamini Mendis

Charles c/o Agnès Rimond Roth

The invention relates to a recombinant protein fabricated in a baculovirus system, of which the essential constitutive polypeptide sequence is that of a C-terminal fragment of 19 kilodalton (p19) of the surface protein 1 (protein MSP-1) of the merozoite parasite of thetype, particularly, which is infectious for humans, said C-terminal fragment remaining normally anchored at the surface of the parasite at the end of its penetration phase into human erythrocytes, in the occurrence of an infectious cycle. Said recombinant protein is applicable to the production of vaccines against malaria.

[object Object]

The invention relates to a recombinant protein fabricated in a baculovirus system, of which the essential constitutive polypeptide sequence is that of a C-terminal fragment of 19 kilodalton (p19) of the surface protein 1 (protein MSP-1) of the merozoite parasite of thetype, particularlywhich is infectious for humans, said C-terminal fragment remaining normally anchored at the surface of the parasite at the end of its penetration phase into human erythrocytes, in the occurrence of an infectious cycle. Said recombinant protein is applicable to the production of vaccines against malaria.

Recombinant protein containing a C-terminal fragment of plasmodium MSP-1

Growing community of inventors

Paris, France

Shirley Longacre-Andre